UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long‐term edaravone efficacy in amyotrophic lateral sclerosis: Post‐hoc analyses of Study 19 (MCI186‐19)

Muscle & nerve, 2020-02, Vol.61 (2), p.218-221

2020

Volltextzugriff (PDF)

Categorization of the amyotrophic lateral sclerosis population via the clinical determinant of post‐onset ΔFS for study design and medical practice

Muscle & nerve, 2024-07, Vol.70 (1), p.36-41

2024

Volltextzugriff (PDF)

Identification of quantitative trait loci for survival in the mutant dynactin p150Glued mouse model of motor neuron disease

PloS one, 2022-09, Vol.17 (9), p.e0274615-e0274615

2022

Volltextzugriff (PDF)

Primary lateral sclerosis (PLS) functional rating scale: PLS‐specific clinimetric scale

Muscle & nerve, 2020-02, Vol.61 (2), p.163-172

2020

Volltextzugriff (PDF)

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III

Annals of neurology, 2009-08, Vol.66 (2), p.235-244

2009

Volltextzugriff (PDF)

Genetic background effects on disease onset and lifespan of the mutant dynactin p150Glued mouse model of motor neuron disease

PloS one, 2015-03, Vol.10 (3), p.e0117848-e0117848

2015

Volltextzugriff (PDF)

Charcot–Marie–Tooth Disease type 4C: Novel mutations, clinical presentations, and diagnostic challenges

Muscle & nerve, 2018-05, Vol.57 (5), p.749-755

2018

Volltextzugriff (PDF)

Hereditary spastic paraplegia: gain-of-function mechanisms revealed by new transgenic mouse

Human molecular genetics, 2019-04, Vol.28 (7), p.1136-1152

2019

Volltextzugriff (PDF)

Phenotype of transgenic mice carrying a very low copy number of the mutant human G93A superoxide dismutase-1 gene associated with amyotrophic lateral sclerosis

PloS one, 2014-06, Vol.9 (6), p.e99879-e99879

2014

Volltextzugriff (PDF)

Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2020-10, Vol.21 (7-8), p.509-518

2020

Volltextzugriff (PDF)

Multidisciplinary Clinics in Neuromuscular Medicine

Continuum (Minneapolis, Minn.), 2023-10, Vol.29 (5), p.1585-1594

2023

Volltextzugriff (PDF)

Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]

PloS one, 2022-06, Vol.17 (6), p.e0258614-e0258614

2022

Volltextzugriff (PDF)

Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial

Journal of neurology, neurosurgery and psychiatry, 2022-08, Vol.93 (8), p.871-875

2022

Volltextzugriff (PDF)

Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial

The Lancet (British edition), 2014-06, Vol.383 (9934), p.2065-2072

2014

Volltextzugriff (PDF)

Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathy

Neurogenetics, 2015-01, Vol.16 (1), p.1-9

2015

Volltextzugriff (PDF)

Understanding the use of NIV in ALS: results of an international ALS specialist survey

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2018-07, Vol.19 (5-6), p.331-341

2018

Volltextzugriff (PDF)

Pulmonary function decline in amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2021-07, Vol.22 (S1), p.54-61

2021

Volltextzugriff (PDF)

Identification of quantitative trait loci for survival in the mutant dynactin p150Glued mouse model of motor neuron disease

PloS one, 2022-09, Vol.17 (9)

2022

Volltextzugriff (PDF)

Use of a new ALS specific respiratory questionnaire: the ARES score

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2021-07, Vol.22 (S1), p.48-53

2021

Volltextzugriff (PDF)

Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia

Nature genetics, 2001-11, Vol.29 (3), p.326-331

2001

Volltextzugriff (PDF)

Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS

Brain research. Molecular brain research., 2004-11, Vol.130 (1), p.7-15

2004

Volltextzugriff (PDF)

NIPPV: a treatment for ALS whose time has come

Neurology, 2006-09, Vol.67 (5), p.736-737

2006

Volltextzugriff (PDF)

TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A

Nature (London), 2022-03, Vol.603 (7899), p.131-137

2022

Volltextzugriff (PDF)

Primary lateral sclerosis: consensus diagnostic criteria

Journal of neurology, neurosurgery and psychiatry, 2020-04, Vol.91 (4), p.373-377

2020

Volltextzugriff (PDF)

A major QTL on mouse chromosome 17 resulting in lifespan variability in SOD1-G93A transgenic mouse models of amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2014-12, Vol.15 (7-8), p.588-600

2014

Volltextzugriff (PDF)

1 – 25 von 203

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(170)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Englisch
(203)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(142)
Life Sciences & Biomedicine
(133)
Humans
(124)
Neurosciences & Neurology
(110)
Clinical Neurology
(105)
Male
(50)
Amyotrophic Lateral Sclerosis
(48)
Female
(46)
Amyotrophic Lateral Sclerosis - Drug Therapy
(35)
Animals
(34)
Adult
(33)
Middle Aged
(33)
Biological And Medical Sciences
(30)
Neurosciences
(28)
Medical Sciences
(26)
Aged
(21)
Amyotrophic Lateral Sclerosis - Therapy
(20)
Neurology
(18)
Als
(17)
Amyotrophic Lateral Sclerosis - Diagnosis
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Long‐term edaravone efficacy in amyotrophic lateral sclerosis: Post‐hoc analyses of Study 19 (MCI186‐19)

Categorization of the amyotrophic lateral sclerosis population via the clinical determinant of post‐onset ΔFS for study design and medical practice

Identification of quantitative trait loci for survival in the mutant dynactin p150Glued mouse model of motor neuron disease

Primary lateral sclerosis (PLS) functional rating scale: PLS‐specific clinimetric scale

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III

Genetic background effects on disease onset and lifespan of the mutant dynactin p150Glued mouse model of motor neuron disease

Charcot–Marie–Tooth Disease type 4C: Novel mutations, clinical presentations, and diagnostic challenges

Hereditary spastic paraplegia: gain-of-function mechanisms revealed by new transgenic mouse

Phenotype of transgenic mice carrying a very low copy number of the mutant human G93A superoxide dismutase-1 gene associated with amyotrophic lateral sclerosis

Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis

Multidisciplinary Clinics in Neuromuscular Medicine

Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]

Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial

Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial

Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathy

Understanding the use of NIV in ALS: results of an international ALS specialist survey

Pulmonary function decline in amyotrophic lateral sclerosis

Identification of quantitative trait loci for survival in the mutant dynactin p150Glued mouse model of motor neuron disease

Use of a new ALS specific respiratory questionnaire: the ARES score

Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia

Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS

NIPPV: a treatment for ALS whose time has come

TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A

Primary lateral sclerosis: consensus diagnostic criteria

A major QTL on mouse chromosome 17 resulting in lifespan variability in SOD1-G93A transgenic mouse models of amyotrophic lateral sclerosis

Suchergebnisse filtern